{
    "symbol": "ORGS",
    "quarter": 3,
    "year": 2022,
    "date": "2022-11-13 21:29:02",
    "content": " We\u00e2\u0080\u0099ve made significant progress in advancing the rollout of our point-of-care platform, and we are very pleased to report another quarter of solid revenues, $8 million and all progressing in our expansion in the U.S. We have invested much effort in terms of our capital raising activities in order to protect shareholders and preserve our capital structure. Cost of revenues development services and research and development for the 3 months ended September 30, 2022 were $4.7 million as compared to $10 million for the 3 months ended September 30, 2021, representing a decrease of 53%. SG&A for the 3 months ended September 30, 2022 were $3.1 million compared to $6.1 million for the same period last year, representing a decrease of 49%. Operating loss for the 3 months ended September 30, 2022, was $7 million  compared to $7.7 million for the same period last year. Net loss for the 3 months ended September 30, 2022 was $1.4 million, a decrease of 86% compared to $10.1 million for the same period last year."
}